Shenzhen Salubris Pharmaceuticals Co., Ltd. (SZSE:002294) announces a share repurchase program. Under the program, the company will repurchase up to CNY 500 million worth of shares. The shares will be repurchased at a price not greater than CNY 30 per share. The shares repurchased will be used for ESOP or for conversion of corporate bonds issued by the company which are convertible to shares. The repurchase program is valid for a period of 12 months.